Ireland
--:--IST
Recruiting Not applicable

Desarda Tissue Technique vs Lichtenstein Technique for Primary Inguinal Hernia Repair

NCT06650878 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2025-03-26
Last updated
2026-10-27

Condition(s) studied

Inguinal Hernia UnilateralComplications of Surgical Procedures or Medical Care

Investigational drug(s) / intervention(s)

DesardaLichtenstein

Desarda: This technique prevent from using a mesh to surgical repair of a inguinal hernia

Lichtenstein: This technique implies using a mesh to surgical repair of a inguinal hernia

Study summary

This study aims to evaluate whether a surgical technique (Desarda) is superior to the commonly used surgical technique (Lichtenstein) in inguinal hernia repair concerning the occurrence of postoperative complications. The Lichtenstein technique involves the use of a mesh, while the Desarda technique does not.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Diagnosed with primary inguinal hernia. * Body mass index below 31 * Indication for inguinal hernia repair via anterior approach, either as outpatient surgery (CMA) or elective admission. * Legal capacity to provide informed consent. Exclusion Criteria: * Patients with a weak, thin, or divided external oblique aponeurosis. * Participants diagnosed with any of the following conditions: * Ongoing oncological disease * Cirrhotic patients classified as Child B or higher * Women who have previously undergone a cesarean section * Cognitive or affective conditions that limit the ability to cooperate with the study procedures

Primary outcome measure(s)

  • Rate of Participants with Post-surgery Complications — 3 months
    Any of the following complications: ● Sensation of a foreign body that persists beyond 3 months after surgery, self-reported by the participant ● Seroma within the first 30 days after surgery, verified through physical examination by a surgeon ● Hematoma within the first 30 days after surgery, verified through physical examination by a surgeon ● Infection at the surgical site within the first 30 days after surgery, verified by a surgeon ● Severe postoperative pain (7 or higher on the visual analog scale \[VAS\]) within the first 30 days after surgery, self-reported by the participant ● Chronic postoperative pain (persisting more than three months after surgery), self-reported by the participant ● Persistent loss of skin sensitivity beyond 30 days after surgery, self-reported by the participant ● Limitation of normal activities at home, outside the home, or at work beyond 3 months after surgery, self-reported by the participant

Trial sites (1)

FacilityCityRegionStatus
CSAPG Sant Pere de Ribes Barcelona Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06650878 on ClinicalTrials.gov ↗ ← All trials in Spain